Nuformix plc (FRA:1RT)
0.0010
-0.0005 (-33.33%)
At close: Nov 28, 2025
Nuformix Statistics
Total Valuation
Nuformix has a market cap or net worth of EUR 6.24 million. The enterprise value is 6.13 million.
| Market Cap | 6.24M |
| Enterprise Value | 6.13M |
Important Dates
The next estimated earnings date is Tuesday, December 30, 2025.
| Earnings Date | Dec 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 2.11B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +49.81% |
| Shares Change (QoQ) | +68.24% |
| Owned by Insiders (%) | 4.46% |
| Owned by Institutions (%) | 74.71% |
| Float | 2.00B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.46 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.36 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -153.80% and return on invested capital (ROIC) is -16.31%.
| Return on Equity (ROE) | -153.80% |
| Return on Assets (ROA) | -14.85% |
| Return on Invested Capital (ROIC) | -16.31% |
| Return on Capital Employed (ROCE) | -79.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.50M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -6,653 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +100.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +100.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 46.10 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -765,621 |
| Pretax Income | -4.52M |
| Net Income | -4.51M |
| EBITDA | -723,494 |
| EBIT | -765,621 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 117,039 in cash and n/a in debt, giving a net cash position of 117,039.
| Cash & Cash Equivalents | 117,039 |
| Total Debt | n/a |
| Net Cash | 117,039 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 965,440 |
| Book Value Per Share | 0.00 |
| Working Capital | -106,597 |
Cash Flow
| Operating Cash Flow | -662,662 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nuformix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.81% |
| Shareholder Yield | -49.81% |
| Earnings Yield | -72.33% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |